title: [Successful treatment of chronic myelomonocytic leukemia (CMMoL) with N4-palmitoyl-1-beta-D-arabinofuranosylcytosine (PLAC)].
authors.forename: M
authors.initials: M
authors.lastname: Ozawa
authors.forename: K
authors.initials: K
authors.lastname: Iwamoto
authors.forename: K
authors.initials: K
authors.lastname: Kitani
authors.forename: T
authors.initials: T
authors.lastname: Mizuno
authors.forename: Y
authors.initials: Y
authors.lastname: Kobayashi
authors.forename: H
authors.initials: H
authors.lastname: Horiuchi
authors.forename: N
authors.initials: N
authors.lastname: Maruo
authors.forename: M
authors.initials: M
authors.lastname: Kondo
authors.forename: S
authors.initials: S
authors.lastname: Horiike
authors.forename: S
authors.initials: S
authors.lastname: Misawa
mesh_terms: D000368:Aged; D000970:Antineoplastic Agents / Q000627:therapeutic use*; D007446:Chromosome Inversion; D002878:Chromosomes, Human, Pair 1; D003561:Cytarabine / Q000031:analogs & derivatives* / Q000627:therapeutic use; D006412:Hematopoietic Stem Cells / Q000187:drug effects / Q000473:pathology; D006801:Humans; D007621:Karyotyping; D015477:Leukemia, Myelomonocytic, Chronic / Q000188:drug therapy* / Q000235:genetics; D008297:Male; D012074:Remission Induction
chemical_list: D000970:Antineoplastic Agents; D003561:Cytarabine; C047643:N(4)-palmitoyl cytarabine